Your browser doesn't support javascript.
loading
In vivo investigation of boron-rich nanodrugs for treating triple-negative breast cancers via boron neutron capture therapy.
Lan, Kai-Wei; Huang, Wei-Yuan; Chiu, Yi-Lin; Hsu, Fang-Tzu; Chien, Yun-Chen; Hsiau, Yong-Yun; Wang, Tzu-Wei; Keng, Pei Yuin.
Affiliation
  • Lan KW; Department of Material Science and Engineering, National Tsing Hua University, Hsinchu City 300, Taiwan, ROC.
  • Huang WY; Department of Material Science and Engineering, National Tsing Hua University, Hsinchu City 300, Taiwan, ROC.
  • Chiu YL; Department of Material Science and Engineering, National Tsing Hua University, Hsinchu City 300, Taiwan, ROC.
  • Hsu FT; Department of Material Science and Engineering, National Tsing Hua University, Hsinchu City 300, Taiwan, ROC.
  • Chien YC; Department of Material Science and Engineering, National Tsing Hua University, Hsinchu City 300, Taiwan, ROC.
  • Hsiau YY; College of Engineering, National Tsing Hua University, Hsinchu City 300, Taiwan, ROC.
  • Wang TW; Department of Material Science and Engineering, National Tsing Hua University, Hsinchu City 300, Taiwan, ROC.
  • Keng PY; Department of Material Science and Engineering, National Tsing Hua University, Hsinchu City 300, Taiwan, ROC. Electronic address: keng.py@mx.nthu.edu.tw.
Biomater Adv ; 155: 213699, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37979440
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Boron Neutron Capture Therapy / Nanoparticles / Triple Negative Breast Neoplasms Limits: Animals / Humans Language: En Journal: Biomater Adv Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Boron Neutron Capture Therapy / Nanoparticles / Triple Negative Breast Neoplasms Limits: Animals / Humans Language: En Journal: Biomater Adv Year: 2023 Type: Article